Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 150.04%94.26M | -113.93%-188.36M | 4.55%1.35B | -21.76%1.29B | 80.85%1.65B | -27.57%913.83M | -10.85%1.26B | 341.20%1.42B | -66.20%320.76M | -62.36%949.06M |
Net profit before non-cash adjustment | -44.76%322.55M | -58.73%583.88M | 7.72%1.41B | 39.07%1.31B | -26.66%944.49M | 0.11%1.29B | 253.19%1.29B | 474.81%364.26M | -139.58%-97.19M | -81.81%245.54M |
Total adjustment of non-cash items | 2.44%331.4M | 48.19%323.5M | -20.67%218.3M | -33.00%275.16M | 633.73%410.69M | -118.39%-76.95M | -15.18%418.45M | -13.43%493.33M | -23.62%569.84M | 59.70%746.1M |
-Depreciation and amortization | 7.99%422.06M | 38.38%390.83M | -10.36%282.42M | -37.50%315.06M | -14.24%504.08M | 18.85%587.8M | -5.99%494.57M | -2.31%526.09M | -17.44%538.52M | 11.98%652.28M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -299.71%-279.53M | 70.58%139.96M |
-Disposal profit | -143.56%-883K | 138.79%2.03M | -120.12%-5.23M | 137.36%25.97M | 89.89%-69.52M | -626.91%-687.82M | -27.79%-94.62M | -2,319.57%-74.05M | -85.63%3.34M | 7.43%23.22M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 187.21%12.45M | --4.33M |
-Other non-cash items | -29.46%-89.78M | -17.75%-69.35M | 10.58%-58.9M | -175.85%-65.87M | -203.49%-23.88M | 24.68%23.07M | -55.17%18.51M | -86.01%41.29M | 500.40%295.07M | 66.34%-73.7M |
Changes in working capital | 48.92%-559.69M | -289.36%-1.1B | 4.83%-281.42M | -199.42%-295.71M | 200.10%297.44M | 32.97%-297.14M | -179.49%-443.27M | 467.11%557.63M | -256.73%-151.9M | -106.04%-42.58M |
-Change in receivables | 155.58%165.29M | -212.01%-297.41M | -47.44%-95.32M | -131.60%-64.65M | -28.02%204.59M | 147.12%284.22M | -2,934.91%-603.18M | -65.41%21.28M | -86.70%61.51M | 129.56%462.63M |
-Change in inventory | 90.46%-70.8M | -906.71%-741.99M | -120.86%-73.71M | 188.71%353.29M | 24.85%-398.23M | -1,953.39%-529.94M | -88.40%28.59M | 136.86%246.47M | -744.16%-668.63M | 67.45%-79.21M |
-Change in payables | -541.85%-682.62M | -223.05%-106.35M | 116.03%86.43M | -337.30%-539.3M | 241.56%227.26M | 161.22%66.54M | 71.58%-108.69M | -182.94%-382.4M | 211.97%461.06M | -169.50%-411.78M |
-Provision for loans, leases and other losses | 181.55%44.15M | 125.07%15.68M | -341.94%-62.53M | 128.92%25.85M | -350.31%-89.36M | 180.19%35.7M | -210.75%-44.52M | --40.2M | ---- | ---- |
-Changes in other current assets | -145.74%-15.7M | 125.19%34.33M | -92.25%-136.3M | -120.07%-70.89M | 329.86%353.18M | -154.00%-153.65M | -54.98%284.54M | 10,925.23%632.09M | 58.95%-5.84M | -109.25%-14.22M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -59.89%-4.68M | -15.15%-2.93M | 19.73%-2.54M | 39.96%-3.17M | 45.38%-5.28M | 23.97%-9.66M | 34.50%-12.7M | 10.07%-19.39M | -11.38%-21.56M | -2.05%-19.36M |
Interest received (cash flow from operating activities) | 19.82%96.98M | 13.71%80.94M | 0.03%71.18M | -0.37%71.16M | -18.99%71.42M | -10.14%88.17M | 23.11%98.12M | -17.27%79.7M | 1.85%96.34M | 33.27%94.59M |
Tax refund paid | 97.10%-12.53M | -2.64%-431.59M | -59.10%-420.47M | 32.39%-264.28M | 0.55%-390.9M | -72.27%-393.07M | -1,190.25%-228.18M | 160.59%20.93M | 89.54%-34.54M | 50.90%-330.19M |
Other operating cash inflow (outflow) | 1.18M | 0 | 0 | 0 | 1,233,100.00%12.33M | 0.00%-1K | 99.99%-1K | 94.99%-7.21M | -143.72M | 0 |
Operating cash flow | 132.33%175.2M | -154.20%-541.93M | -8.82%999.96M | -18.17%1.1B | 123.64%1.34B | -46.45%599.27M | -24.86%1.12B | 585.40%1.49B | -68.70%217.28M | -63.48%694.1M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -19.09%-439.83M | -38.56%-369.32M | 5.49%-266.54M | 31.93%-282.02M | 8.57%-414.28M | -58.00%-453.12M | 45.49%-286.78M | -65.85%-526.08M | 50.11%-317.21M | -8.30%-635.86M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --603.78M | ---- | ---- | ---- | -79.11%-28.21M |
Net investment product transactions | -141.58%-89.55M | 2,910.82%215.37M | 60.56%-7.66M | -106.80%-19.43M | 168.17%285.67M | -66.05%-419.05M | -33.93%-252.37M | 12.06%-188.43M | -27.90%-214.26M | 62.08%-167.52M |
Advance cash and loans provided to other parties | ---40M | --0 | ---- | ---- | ---20M | ---- | ---- | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | -0.50%4.96M | -16.20%4.99M | -24.04%5.95M | 535.71%7.83M | -95.61%1.23M | -23.91%28.04M | -80.76%36.85M | 330.26%191.54M | 20.10%44.52M | 42.85%37.07M |
Net changes in other investments | -44.12%-28.78M | 8.94%-19.97M | -210.70%-21.93M | 148.18%19.81M | 3.54%-41.12M | -251.62%-42.63M | 32.53%28.11M | 105.89%21.21M | -25.07%-360.2M | 15.46%-288.01M |
Investing cash flow | -251.13%-593.19M | 41.78%-168.94M | -5.98%-290.18M | -45.25%-273.8M | 33.38%-188.5M | 40.32%-282.97M | 5.49%-474.19M | 40.77%-501.76M | 21.74%-847.16M | 20.37%-1.08B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -157.71%-14.31M | 233.36%24.8M | 106.50%7.44M | 14.85%-114.41M | -34.93%-134.35M | 69.20%-99.57M | -161.39%-323.26M | 221.24%526.56M | -69.31%163.92M | 1,180.32%534.15M |
Net common stock issuance | -511.11%-55K | 70.97%-9K | 39.22%-31K | 22.73%-51K | 99.99%-66K | -442,351.82%-606.16M | ---137K | ---- | ---- | -5.62%-94K |
Increase or decrease of lease financing | -67.81%-1.28M | 65.04%-761K | 13.47%-2.18M | 70.22%-2.52M | ---8.45M | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -0.10%-211.63M | 14.39%-211.42M | -58.75%-246.96M | -0.30%-155.56M | 4.20%-155.09M | -6.61%-161.89M | 0.71%-151.86M | -0.85%-152.95M | 0.04%-151.66M | -0.13%-151.73M |
Net other fund-raising expenses | -100.00%-2K | ---1K | ---- | ---1K | ---- | 0.00%-1K | 0.00%-1K | ---1K | ---- | 0.00%-1K |
Financing cash flow | -21.28%-227.27M | 22.48%-187.4M | 11.30%-241.73M | 8.53%-272.53M | 65.66%-297.95M | -82.56%-867.62M | -227.21%-475.26M | 2,949.17%373.62M | -96.80%12.25M | 290.15%382.33M |
Net cash flow | ||||||||||
Beginning cash position | -7.34%9.72B | 6.80%10.49B | 6.02%9.82B | 10.02%9.27B | -6.88%8.42B | 2.38%9.04B | 16.50%8.83B | -8.44%7.58B | 2.28%8.28B | 8.14%8.1B |
Current changes in cash | 28.17%-645.26M | -291.92%-898.27M | -14.95%468.05M | -35.54%550.32M | 254.85%853.73M | -425.21%-551.33M | -87.54%169.53M | 320.38%1.36B | -10,020.01%-617.62M | -101.79%-6.1M |
Effect of exchange rate changes | -3.15%124.36M | -35.73%128.41M | 2,545.80%199.81M | 175.66%7.55M | 85.87%-9.98M | -274.99%-70.64M | 136.80%40.37M | -35.45%-109.71M | -142.52%-81M | -29.22%190.48M |
Cash adjustments other than cash changes | 200.00%1K | ---1K | ---- | ---- | -100.00%-2K | ---1K | ---- | ---1K | ---- | 0.00%1K |
End cash Position | -5.36%9.2B | -7.34%9.72B | 6.80%10.49B | 6.02%9.82B | 10.02%9.27B | -6.88%8.42B | 2.38%9.04B | 16.50%8.83B | -8.44%7.58B | 2.28%8.28B |
Free cash flow | 71.25%-267.06M | -229.15%-929.02M | -11.09%719.33M | -12.29%809.03M | 568.29%922.37M | -83.20%138.02M | -13.83%821.43M | 665.92%953.25M | -465.99%-168.44M | -96.47%46.02M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |